Randomised trials have shown that ultra-hypofractionated radiotherapy [uHFRT] is a safe alternative for breast radiotherapy [RT].
However, its safety in patients requiring tumour bed boost cannot be firmly established as none of the patients in the FAST trial and only a quarter of the patients in the FAST-FORWARD trial were offered tumour bed boost.
